Theravance Biopharma TBPH Business Segments — Other Nonoperating Income Expense

Similar metrics at other companies

QURESingle Reportable — Other Nonoperating Income Expense

$199K-96.1%

CAPRSingle Reportable — Other Nonoperating Income Expense

-$73K+47.2%

SRRKSingle Reportable — Other Nonoperating Income Expense

$3.49M+248%

POWISingle Reportable — Other Operating Income Expense Net

$0—

PAYOSingle Reportable — Other Operating Income Expense Net

-$47.43M-5.4%

XOMASingle Reportable — Other Nonoperating Income Expense

$4.72M+5,069%

Questions, answered.

What is Theravance Biopharma's business segments — other nonoperating income expense?

Theravance Biopharma (TBPH) reported business segments — other nonoperating income expense of $3.01M in Q1 2026.

How has Theravance Biopharma's business segments — other nonoperating income expense changed year-over-year?

Theravance Biopharma's business segments — other nonoperating income expense increased by 220.9% year-over-year, from $939K to $3.01M.

What is the long-term trend for Theravance Biopharma's business segments — other nonoperating income expense?

Over 2 years (2023 to 2025), Theravance Biopharma's business segments — other nonoperating income expense has grown at a 5.6% compound annual growth rate (CAGR), from $9.12M to $10.17M.

What does business segments — other nonoperating income expense mean?

This captures miscellaneous financial gains or losses that fall outside the scope of the segment's primary business operations, such as foreign exchange fluctuations or minor investment income. It provides context on peripheral financial activities that impact the segment's bottom line but are not reflective of core performance.